Arm Holdings is under fresh pressure after reports that the US Federal Trade Commission (FTC) has launched an antitrust investigation into its semiconductor licensing practices. The British chip design giant, long seen as a neutral provider of processor blueprints to the global semiconductor industry, is now facing questions over whether its business model could be restricting competition.
Following the news, Arm (ARM) shares fell sharply, sliding around 8% as investors reacted to growing regulatory uncertainty and the possibility of prolonged legal scrutiny in both the US and other key markets.
According to details emerging from the investigation, the FTC is assessing whether Arm has the ability, or intent, to deny or worsen licensing terms for its chip architecture customers. These blueprints are essential for companies designing central processing units (CPUs) used in smartphones, data centers, and AI systems.
Arm Holdings plc American Depositary Shares, ARM
Regulators have reportedly instructed Arm to preserve internal documents as part of the ongoing review, signaling that the probe is in its early but active stages. The inquiry adds another layer of pressure on the company’s licensing strategy, which has historically been one of its most valuable and tightly controlled revenue streams.
The US probe is not happening in isolation. Arm is already facing increased regulatory attention in other jurisdictions, including an ongoing investigation by South Korea’s antitrust authority. Together, these developments suggest growing global discomfort with the concentration of power in semiconductor intellectual property markets.
At the same time, Arm is still dealing with a high-profile contractual dispute involving Qualcomm following the US chipmaker’s acquisition of Nuvia. The case has raised broader questions about how Arm’s licensing agreements are enforced and whether its business practices may be evolving in ways that could affect customers differently depending on contract structures.
Arm’s legal challenges with Qualcomm have further intensified scrutiny. A Delaware jury previously sided with Qualcomm and its subsidiary Nuvia on key claims involving licensing rights, weakening Arm’s position in one of its most closely watched disputes.
Arm had argued that certain architecture licenses could not be transferred without explicit approval, while Qualcomm countered that its agreements already covered the disputed chip designs. The mixed rulings highlighted the complexity of Arm’s licensing framework and the blurred boundaries between customer rights and platform control.
Analysts note that the FTC’s renewed attention may reflect broader concerns raised during earlier blocked deals involving Arm, including Nvidia’s attempted acquisition. At the time, regulators warned that Arm’s neutral licensing role was critical to maintaining competition across the semiconductor industry.
The 8% drop in Arm’s stock underscores investor sensitivity to regulatory risk, especially given the company’s central position in global chip design infrastructure. While demand for Arm-based architectures continues to grow, particularly in AI and mobile computing, the possibility of prolonged antitrust proceedings introduces uncertainty over future licensing flexibility and pricing power.
For now, Arm remains a foundational player in semiconductor innovation. However, the outcome of the FTC investigation could reshape how its licensing model is viewed and potentially influence how chip design IP is controlled across the broader tech ecosystem.
The post Arm (ARM) Stock; Slips 8% as US FTC Launches Antitrust Probe Into Licensing Practices appeared first on CoinCentral.

